secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001628908-21-000142
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Q3 revenue $222.5M (-7.1% YoY); net loss $13M; board adds Dr. Tunde Sotunde
--------------------------------------------------------------------------------

- GAAP revenue $222.5M, down 7.1% YoY; revenue ex-divested assets up 36.3%.
- Net loss attributable to common $13.0M; Adjusted EBITDA $13.8M.
- Total lives managed 14.7M (1.6M EHS, 13.1M Clinical Solutions).
- New partnerships: Sunflower Medical Group, Northern Medical Group, Health New England; 10 partner additions in 2021.
- Board: Dr. Tunde Sotunde appointed; Frank Williams to non-executive Chairman effective Jan 1, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890821000142/0001628908-21-000142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890821000142/evh-20211028.htm
  HTML page:      https://secwatch.observer/filing/0001628908-21-000142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer